Back to results
US 6,274,336 B1Granted
Method of inhibiting cathepsin K
AssigneeSmithKline Beecham Corporation
InventorsSherin Salaheldin Abdel-Meguid, Renee Louise Desjarlais, Cheryl Ann Janson, Ward Whitlock Smith, Jr., Baoguang Zhao
Life of this patent
Estimating the term…
Abstract
A novel cathepsin K crystalline stucture is identified. Also disclosed are methods of identifying inhibitors of this protease and methods of inhibiting cathepsin K using inhibitors with certain structural, physical and spatial characteristics.
Claims1
A method of identifying an inhibitor compound capable of binding to, and inhibiting the proteolytic activity of, cathepsin K, said method comprising:
- introducing the protein coordinates of Table I into a suitable computer program so as to define an active site conformation of a cathepsin K molecule comprising an active site formed by the residues listed in Table XXIX, said active site defined by the protein coordinates of Table I, wherein said program displays the three- dimensional structure of the active site;
- creating a three dimensional representation of the active site in said computer program;
- displaying and superimposing a three dimensional representation of a test compound on the three dimensional representation of the active site;
- assessing whether said test compound fits spatially into the active site;
- preparing said test compound that fits spatially into the active site;
- using said test compound in a biological assay for a protease characterized by said active site;
- and
- determining whether said test compound inhibits cathepsin K activity in said assay.
5 more elements
Dependencies are inferred from the claim text.